Bispecific Antibodies and Antibody–Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs
Andreev, Julian, Thambi, Nithya, Perez Bay, Andres E., Delfino, Frank, Martin, Joel, Kelly, Marcus P., Kirshner, Jessica R., Rafique, Ashique, Kunz, Arthur, Nittoli, Thomas, MacDonald, Douglas, Daly,Volume:
16
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-16-0658
Date:
April, 2017
File:
PDF, 8.47 MB
english, 2017